Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Spray Combined With Intravenous Lidocaine on Postoperative Pain After Myomectomy
NCT07268495Recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (4 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Incidence rate of moderate to severe pain at 24 hours. Started Aug 2024; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07268495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07268495.